Finished
Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy
NCT02258906 · Yonsei University · Updated 25 Aug 2016
- What is being tested
- ulinastatin; normal saline
- For
- Renal Mass
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 79 years. About 66 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started Oct 2014, ends July 2016. Registered 8 Oct 2014.
- Results
- None posted yet.
In the researchers' words
Ulinastatin reduces systemic inflammatory responses and protects organs from ischemia/reperfusion-induced injury. The aim of this study is to evaluate the effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy. Seventy patients, aged 20 to 79 years, scheduled for robot-assisted laparoscopic partial nephrectomy will be divided into ulinastatin (n=35) and control (n=35) groups. Randomly selected patients of the ulinastatin group are given ulinastatin. In contrast, patients in the control group receive an equivalent volume of normal saline as a placebo. The primary endpoints are postoperative renal function measured by serum creatinine, cystatin C, and urine output.
Sites
- Severance Hospital, Yonsei University College of MedicineSeoul, South Korea